Showing results (21-30 of 88) with videos related to

Sort By:
Pageof 9
The American Journal of Tropical Medicine and Hygiene|May 23, 2019
Albumin-Bilirubin Score Differentiates Liver Fibrosis Stage and Hepatocellular Carcinoma Incidence in Chronic Hepatitis B Virus Infection: A Retrospective Cohort StudyKoji Fujita, Takako Nomura, Asahiro Morishita, et al.
Internal Medicine (Tokyo, Japan)|December 28, 2017
Severe Steroid-responsive Skin Disorders Related to Ledipasvir and Sofosbuvir for HCVTomoko Tadokoro, Asahiro Morishita, Koji Fujita, et al.
Experimental and Therapeutic Medicine|August 18, 2018
Grazoprevir/elbasvir treatment for the relapse of HCV genotype 1b infection after ledipasvir/sofosbuvir: A case reportTomoko Tadokoro, Asahiro Morishita, Kyoko Oura, et al.
Internal and Emergency Medicine|March 30, 2021
Prognosis of probable autoimmune hepatitis patients: a single-center study in JapanKoji Fujita, Kyoko Oura, Tomoko Tadokoro, et al.
Molecular and Clinical Oncology|June 28, 2021
Multimodal treatment involving molecular targeted agents and on-demand transcatheter arterial chemoembolization for advanced hepatocellular carcinoma: A case report and review of the literatureKyoko Oura, Kei Takuma, Mai Nakahara, et al.
Journal of Clinical Medicine|August 22, 2019
Prediction of Transplant-Free Survival through Albumin-Bilirubin Score in Primary Biliary CholangitisKoji Fujita, Takako Nomura, Asahiro Morishita, et al.
Journal of Clinical Medicine|February 13, 2026
The Involvement of Apoptosis Inhibitor of Macrophage in the Disease Severity of Primary Biliary CholangitisTakashi Himoto, Erika Mori, Manami Tanimoto, et al.
Journal of Clinical Medicine|December 11, 2025
Autoantibodies in Primary Biliary Cholangitis: From Classical Markers to Emerging TargetsShima Mimura, Asahiro Morishita, Kyoko Oura, et al.
Internal and Emergency Medicine|January 27, 2021
Effect of pegylated interferon alfa-2a in HBeAg-negative chronic hepatitis B during and 48 weeks after off-treatment follow-up: the limitation of pre-treatment HBsAg load for the seroclearance of HBsAgShima Mimura, Koji Fujita, Kei Takuma, et al.
Journal of Clinical Medicine|September 14, 2018
Fibrosis Staging Using Direct Serum Biomarkers is Influenced by Hepatitis Activity Grading in Hepatitis C Virus InfectionKoji Fujita, Noriyuki Kuroda, Asahiro Morishita, et al.
Pageof 9